Surgery Doctors in Newburyport, MA Accepting Medicare

6 Surgery doctors found. Showing 1 - 6

Jeffrey M Bentley, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 21 Highland Ave, Suite 7, Newburyport, MA 01950 Phone: 978-465-8000    Fax: 978-465-2903

David J Swierzewski, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 7 Graf Rd, Newburyport, MA 01950 Phone: 978-462-8006    Fax: 978-268-5020

Dr. Peter A. Hartmann, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 21 Highland Ave, Suite 12, Newburyport, MA 01950 Phone: 978-463-8686

Brett Joseph Matthews, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 21 Highland Ave Ste 3, Newburyport, MA 01950 Phone: 978-572-1149    Fax: 978-465-4069

Dr. Jeffrey P. Thurlow, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 21 Highland Ave Ste 3, Newburyport, MA 01950 Phone: 978-572-1149    Fax: 978-465-4069

Dr. Michael Melvin Fuenfer, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 25 Highland Ave, Wound Care Center, Newburyport, MA 01950 Phone: 978-762-4888    Fax: 978-762-3922

News Archive

Medicare, abortion grab attention in some House, Senate races

News outlets offer another round of coverage on the Wisconsin Senate race and a tight New York House race, while candidates' views on abortion are spotlighted in Indiana and Missouri.

Gender not an independent predictor of mortality post-PCI

New research shows that women undergoing percutaneous coronary intervention (PCI), also known as angioplasty, exhibit more co-morbidities and cardiovascular risk factors than men. Risk-adjusted analyses have now indicated that, in the contemporary era, gender is not an independent mortality predictor following PCI according to the study now available in Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions.

Bristol-Myers Squibb and Mylan expand access to HIV drug Reyataz in sub-Saharan Africa and India

Bristol-Myers Squibb Company today announced a new agreement to expand access to Reyataz (atazanavir sulfate). The immunity-from-suit agreement signed with Matrix Laboratories Limited, a Mylan Company, enables the generic company to manufacture and sell atazanavir, as well as stavudine and didanosine, in sub-Saharan Africa and India.

Johnson & Johnson completes acquisition of Alios BioPharma

Johnson & Johnson today announced the completion of the acquisition of Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for a total purchase price of approximately $1.75 billion in cash.

Biomarkers that are predictive of clinical benefit in Trop-2-expressing triple-negative breast cancer

Oncotarget recently published "Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer" which reported that the authors investigated whether Trop-2-expression and homologous recombination repair of SN-38-mediated double-strand DNA breaks play a role in the sensitivity of triple-negative breast cancer to SG.

Read more Medical News

› Verified 2 days ago